The steroid, 19-hydroxyandrost-4-ene-3, 17-dione (19-hydroxyandrostenedione, 19-OH-A-dione) has been known to enhance the mineralocorticoid action of aldosterone. To investigate the age-related change in the plasma 19-OH-Adione concentration, plasma 19-OH-A-dione, androst-4-ene-3, 17-dione (A-dione), aldosterone and cortisol of 38 non-hypertensive healthy subjects (18 young men and 20 aged men) measured by specific radioimmunoassays.
The C19 steroid, 19-hydroxyandrost-4-ene-3, 17-dione (19 -hydroxyandrostenedione, 19-OH-A-dione) possesses the amplifying effect of the action of aldosterone (Sekihara, 1983a) . The administration of this steroid caused salt-retention and hypertension in rat (Sekihara, 1983a; Manabe et al., 1984 ).
An aromatase inhibitor, delta 1-testololactone enhanced the hypertensinogenic action of 19-OH-A-dione by inhibiting the degradation of 19-OH-A-dione (Sekihara et al., 1987) . Sekihara et al.(1985) showed that 19-OH-A-dione was present in human circulating blood. Moreover, the plasma 19-OH-A-dione concentration in pregnant women with hypertension (Martin et al., 1985) and in hypertensive patients (Sekihara, 1983b) were reported to be higher than that in non pregnant and non hypertensive subjects. It is well known that plasma A-dione 
Discussion
We earlier demonstrated an age-related decrease in plasma A-dione as well as dehydroepiandrosterone sulfate, a major adrenal androgen in humans (Akamine et al. 1974) . Recently, Sekihara et al. proposed that 19-OH-A-dione is present in human plasma irrespective of the source of synthesis, and acts as an amplifier of mineralocorticoid action of aldosterone (Sekihara 1983a) . It is intriguing to search for the age-related change in the plasma 19-OH-A-dione concentration because this steroid may be a product of the adrenal zona reticularis cells, in which the steroidogenic function declined to senescence in human subjects. In the present study, we found an age-related decrease in plasma 19-OH-A-dione (Fig. 1  right) . This finding sugessts that the plasma concentration of 19-OH-A-dione, may be another age-affected adrenocortical steroid in addition to adrenal androgens.
The organs from which plasma 19-OH-A-dione is derived are not well documented. Sekihara et al.(1985) proposed that 19-OH-A-dione may be produced by the human adrenal gland, based on the evidence that the adrenal vein were an order of magnitude higher than those in the inferior vena cava, and its release was regulated by ACTH and angiotensin II. Recently, we obtained evidence that 19-OH-A-dione was secreted directly by adrenal cells in a primary monolayer culture (Higuchi et al., 1989) . Although 19-OH-A-dione is apparently produced by the adrenal glands, whether this steroid is also produced by any other organ remains to be clarified. In the present study, we found a positive correlation between plasma 19-OH-A-dione and A-dione (Fig. 2) . Martin et al.(1986) also reported a significant positive correlation between plasma 19-OH-Adione and A-dione concentrations in hypertensive pregnant women.
As plasma Adione is derived from the adrenal gland and gonads, it is possible that 19-OH-Adione is produced by the gonads or other tissues retaining 19-hydroxylase activity (Ohigashi et al. 1989) .
In this study, plasma aldosterone and cortisol tended to decrease in aged men, but no significance could be demonstrated. These findings are consistent with the previous observation that the basal concentration and response to ACTH of plasma cortisol and aldosterone in aged men are essentially the same as those in young men (Ohashi et al., 1986) .
To sum up, we demonstrated an agerelated decrease in basal plasma 19-OH-Adione, and also its positive correlation with plasma A-dione.
